Search - tctmd.com

Displaying 261 - 280 of 421

Sort: Relevancy | Date

News Daily News

Registry Data Suggest Protection Up to 2 Years With LAA Closure

Caitlin E. Cox

January 28, 2015

News Daily News

High Mortality After Carotid Stenting in Medicare Patients May Compromise the Treatment’s Benefits

January 28, 2015

News Daily News

Los Datos de Registro Sugieren Protección Hasta 2 Años con el Cierre del AAI

Caitlin E. Cox

January 28, 2015

News Daily News

La Alta Mortalidad Post-Implantación de Stent Carotídeo en Pacientes de Medicare podría Comprometer los Beneficios del Tratamiento

January 28, 2015

News Industry News

InspireMD Announces Important Clinical Data from MASTER and CARENET Trials

December 14, 2014

News Daily News

German Registry Shows Trends in CAS Practice, Outcomes Over 15 Years

Yael L. Maxwell

December 04, 2014

News Daily News

Embolic Protection Stent Most Helpful in STEMI Patients With Large Thrombus

December 04, 2014

News Daily News

Un Registro Alemán revela Tendencias en la Práctica CAS y Resultados a los 15 Años

Yael L. Maxwell

December 04, 2014

News Daily News

El Stent de ‘Protección Embólica’ es Muy Útil en Pacientes STEMI con Trombos Grandes

December 04, 2014

News Daily News

Carotid Stenting, Endarterectomy Equally Effective at Preventing Severe Strokes in Symptomatic Patients

L.A. McKeown

October 24, 2014

News Daily News

La Implantación de Stents Carotídeos y la Endarterectomía son Igual de Efectivas en Pacientes Sintomáticos

L.A. McKeown

October 24, 2014

News Industry News

InspireMD Resumes MGuard Prime Sales and Prioritizes DES and Carotid - New Product Programs

October 14, 2014

News Industry News

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

October 10, 2014

News Industry News

InspireMD to Host Conference Call and Webinar and to Discuss Recently Released Results of CGuard™ CARENET Trial on September 24th

September 18, 2014

News Industry News

InspireMD Announces Positive Results from CGuard™ CARENET Trial with 0% MACE reported at 30 Days

September 16, 2014

News Conference News TCT 2014

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

September 15, 2014

News Industry News

Cerebral Protection Device Reduces Brain Injury Risk in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

September 13, 2014

News Industry News

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

September 02, 2014

News Conference News ESC 2014

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

Todd Neale

September 01, 2014

News Industry News

InspireMD to Announce Results of CGuard™CARENET Trial at the TCT Innovation Session on Late Breaking Early Human Clinical Studies

August 11, 2014

Advertisement

Registry Data Suggest Protection Up to 2 Years With LAA Closure

High Mortality After Carotid Stenting in Medicare Patients May Compromise the Treatment’s Benefits

Los Datos de Registro Sugieren Protección Hasta 2 Años con el Cierre del AAI

La Alta Mortalidad Post-Implantación de Stent Carotídeo en Pacientes de Medicare podría Comprometer los Beneficios del Tratamiento

InspireMD Announces Important Clinical Data from MASTER and CARENET Trials

German Registry Shows Trends in CAS Practice, Outcomes Over 15 Years

Embolic Protection Stent Most Helpful in STEMI Patients With Large Thrombus

Un Registro Alemán revela Tendencias en la Práctica CAS y Resultados a los 15 Años

El Stent de ‘Protección Embólica’ es Muy Útil en Pacientes STEMI con Trombos Grandes

Carotid Stenting, Endarterectomy Equally Effective at Preventing Severe Strokes in Symptomatic Patients

La Implantación de Stents Carotídeos y la Endarterectomía son Igual de Efectivas en Pacientes Sintomáticos

InspireMD Resumes MGuard Prime Sales and Prioritizes DES and Carotid - New Product Programs

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

InspireMD to Host Conference Call and Webinar and to Discuss Recently Released Results of CGuard™ CARENET Trial on September 24th

InspireMD Announces Positive Results from CGuard™ CARENET Trial with 0% MACE reported at 30 Days

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

Cerebral Protection Device Reduces Brain Injury Risk in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

InspireMD to Announce Results of CGuard™CARENET Trial at the TCT Innovation Session on Late Breaking Early Human Clinical Studies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content